Q2 2026 key highlightsNNIT’s financial performance was in line with initial expectations, despite continued customer caution, particularly within the life science segments. However, order entry improved during the quarter across all regions, supported by targeted growth initiatives aimed at strengthening sales execution. Reported group revenue declined 4.5% to DKK 441.6m, corresponding to constant currency revenue growth of -4.4%. The decline was primarily driven by the life science regions, while Public DK and SCALES delivered solid growth contributions. Group EBIT excl. special items came in at DKK 21.4m in the second quarter, corresponding to a margin of 4.8% which remained broadly stable year-over-year, reflecting the impact of cost-reduction initiatives launched during last year, supplemented by further actions taken during...

Nanterre, 27 August 2026 VINCI Autoroutes and VINCI Airports traffic in July 2026 I-      Change in VINCI Autoroutes’ intercity networks traffic  July YTD at the end of July (7 months)  % change 2026/2025 % change 2026/2025VINCI Autoroutes -1.8% -2.7%Light vehicles -1.9% -3.4%Heavy vehicles -0.9% +1.2%In July, light-vehicle traffic fell by 1.9%. It continues to be impacted by the sharp rise in fuel prices that occurred in March, and by the negative effects of heatwaves. It should be noted, however, that the decline was mitigated by a favorable calendar effect*. Heavy vehicle traffic, meanwhile, posted a slight decline of -0.9%. *The back-and-forth between “July holidaymakers” and “August holidaymakers” began on Friday, July 31 this year (compared to Friday, August 1 in 2025). II-      Change in VINCI Airports passenger...

Bestyrelsen for Investeringsforeningen Gudme Raaschou har i dag den 27. august 2026 godkendt foreningens halvårsrapport for 2026. Halvårsrapporten er vedhæftet denne meddelelse og kan endvidere downloades fra foreningens hjemmeside www.lsinvest.dk samt rekvireres ved henvendelse til Invest Administration A/S, Badstuestræde 20, 1209 København K, tlf. 3814 6600. Med venlig hilsen Bestyrelsenfor Investeringsforeningen Gudme RaaschouAttachmentGudme Raaschou – Halvårsrapport 2026

HONG KONG, Aug. 27, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.8245 billion, a 22.2% year-on-year increase, and adjusted net profit of RMB 18.7 million, up 6.4% from the same period last year. The results reflect the Company’s continued execution of its “AI + chronic care” strategy amid favorable policy momentum under China’s 15th Five-Year Plan. Fangzhou’s user and physician networks also expanded during the period. Cumulative registered users exceeded 59.8 million, while average monthly active users increased 23.1% to 14.7 million. Registered physicians reached 282,000. The Company’s supply chain included more than 1,800...

Highlights of the second quarter include:Net income increased 10% to $65.6 million, and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million, and Adjusted EBITDA margin increased to 48% from 46% last year. Revenue increased 8% to $350.7 million. Net income per diluted share rose 15% to $0.78 from $0.68 one year ago, and non-GAAP net income per diluted share increased 15% to $1.24. Total HSA Assets grew 14% to $37.9 billion. Returned $108.1 million to shareholders through stock repurchases.DRAPER, Utah, Aug. 27, 2026 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (“HSA”) custodian by account volume and a leader in consumer-directed benefits (“CDBs”),...

Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 – $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 – $3.2 million)  Ended Fiscal Q3 2026 with $0.9M in cash and cash equivalents (Fiscal Q4 2025 – $5.8 million) and on August 12, 2026 closed $10 million public offering Received $1.25 Million Ontario Life Sciences Scale-Up Fund Milestone Payment Achieved U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System Added to Clinical Evidence Supporting Hybrid IVUS-OCT ImagingTORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) —  Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally...

Landsbréf – BÚS I árshlutareikningur 30. júní 2026 AttachmentLandsbréf – BÚS I árshlutareikningur 30. júní 2026

Bestyrelsen for Investeringsforeningen Maj Invest har på et bestyrelsesmøde d.d. godkendt halvårsrapporten for første halvår 2026. Den godkendte rapport kan ses nedenfor. Venlig hilsen Investeringsforeningen Maj InvestAttachmentHalvårsrapport 2026

Landsbréf hf. hafa birt árshlutareikning fyrir fyrri hluta ársins 2026.  Helstu niðurstöður voru þessar:Hagnaður Landsbréfa eftir skatta var tæpar 603 milljónir króna á fyrri hluta ársins 2026 samanborið við tæpar 457 milljónir króna fyrir sama tímabil árið áður. Hreinar rekstrartekjur námu 1.367 milljónum króna á fyrri hluta ársins 2026 samanborið við 1.142 milljón króna fyrir sama tímabil árið áður. Eigið fé í lok tímabils var rúm 3.971 milljón króna samanborið við rúmar 4.368 milljónir króna í árslok 2025, en félagið greiddi móðurfélagi sínu Landsbankanum 1.000 milljóna króna arðgreiðslu í maí síðastliðnum. Eiginfjárhlutfall Landsbréfa var 74,29% við lok fyrri árshelmings.Helgi Þór Arason, framkvæmdastjóri Landsbréfa: „Rekstur Landsbréfa gekk vel á tímabilinu og hagnaður á tímabilinu endurspeglar traustan rekstur félagsins. Markaðsaðstæður...

Board Authorizes Fiscal 2027 Share Repurchase Program of $70 Million LOUDON, Tenn., Aug. 27, 2026 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2026. Fourth Quarter Fiscal 2026 Highlights Compared to Fourth Quarter Fiscal 2025Net sales increased 42.7% to $295.5 million Unit volume increased 19.2% to 1,456 units Gross profit increased 59.4% to $52.2 million General and administrative expenses increased to $31.8 million GAAP net income increased 53.7% to $7.4 million GAAP net income available to Class A Common Stock per share (diluted) increased 54.2% to $0.37 per share Adjusted EBITDA increased 72.7% to $33.9 million Adjusted net income per share increased 119.0% to $0.92 per share on a weighted average share count of 19.7 million shares...